Tag: Pharmaceutical Industry

A majority of Americans don't want to sacrifice safety in exchange for getting new treatments faster to the market, a new poll finds. (AP Photo/Andrew Welsh-Huggins)

Americans prioritize safety over speedy drug approval, poll finds

Robert King · May 11, 2016 2:51 pm

AARP said in comments on the proposed rule that were due Monday that seniors need relief from high drug prices. (FILE Bloomberg/Tannen Maury)

Drug industry, AARP fight over Medicare changes

Robert King · May 10, 2016 4:01 am

—œPeople are raising issues that we need to think about,—? said Patrick Conway, who added that the agency will address their concerns. (AP Photo)

Administration defends controversial Medicare overhaul

Robert King · May 4, 2016 4:00 pm

The agency issued an updated label for the antidepressant aripiprazole, the active ingredient in Abilify, Abilify Maintena and Aristada. (Bloomberg/Daniel Acker)

FDA: Antidepressant can cause gambling, binge eating, shopping and sex

Robert King · May 3, 2016 9:22 pm

Editorial cartoons

Editorial cartoon: Rest in opioid

Washington Examiner · May 3, 2016 7:00 pm

Shkreli is charged with using an investment fund to prop up the earnings for the Retrophin. (AP Photo/Susan Walsh, File)

Shkreli may face more charges

Robert King · May 3, 2016 6:26 pm

Insurers still have ways of imposing undue costs and burdens on customers — particularly those suffering from chronic and serious health conditions. (iStock photo)

It’s time to end all types of healthcare discrimination

Carl Schmid · May 2, 2016 4:03 am

Sens. Susan Collins, R-Maine, and Claire McCaskill, D-Mo., filed legislation in March calling for the agency to change the way it prioritizes generic drug applications. (AP Photo/Manuel Balce Ceneta)

FDA takes aim at high-priced generics

Robert King · May 2, 2016 4:01 am

On Thursday, the FDA authorized Quest Diagnostics to offer the first commercial test for the Zika virus in the United States. (AP Photo/Arnulfo Franco, File)

FDA approves Zika test

Robert King · April 29, 2016 6:53 pm

Salary of $67 million will be "difficult for them to manage in the court of public opinion," McCaskill says. (AP Photo/Manuel Balce Ceneta)

Senator: New Valeant CEO’s pay ‘tone deaf’

Robert King · April 27, 2016 11:24 pm

"I think it is misleading to act as if this is a problem with four drugs. This is the business model," Claire McCaskill said of Valeant. (AP Photo)

Senator: Drugmaker’s high prices not isolated

Robert King · April 27, 2016 9:54 pm

"Valeant and its shareholders may have changed its tune in recent months, but make no mistake," said Sen. Claire McCaskill, D-Mo. (AP Photo/Manuel Balce Ceneta, File)

Senators not buying drugmaker’s contrition

Robert King · April 27, 2016 8:38 pm